Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

BioAtla (BCAB) Accumulated Depreciation & Amortization (2020 - 2025)

BioAtla (BCAB) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 24.2% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, down 24.2%, while the annual FY2025 figure was $5.3 million, 24.2% down from the prior year.
  • Accumulated Depreciation & Amortization hit $5.3 million in Q4 2025 for BioAtla, down from $7.4 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $7.4 million in Q3 2025 and bottomed at $3.4 million in Q1 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $5.6 million, with a median of $5.8 million recorded in 2023.
  • Year-over-year, Accumulated Depreciation & Amortization surged 38.66% in 2021 and then dropped 24.2% in 2025.
  • BioAtla's Accumulated Depreciation & Amortization stood at $4.3 million in 2021, then grew by 26.0% to $5.4 million in 2022, then increased by 13.31% to $6.1 million in 2023, then increased by 15.22% to $7.0 million in 2024, then decreased by 24.2% to $5.3 million in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $5.3 million, $7.4 million, and $7.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.